XERS - Xeris Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XERS is currently covered by 2 analysts with an average price target of $11.7. This is a potential upside of $3.89 (49.81%) from yesterday's end of day stock price of $7.81.

Xeris Pharmaceuticals's activity chart (see below) currently has 25 price targets and 27 ratings on display. The stock rating distribution of XERS is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.8% with an average time for these price targets to be met of 158.5 days.

Highest price target for XERS is $8, Lowest price target is $4, average price target is $6.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 07-Mar-2025. First documented stock forecast 16-Jul-2018.

Best performing analysts who are covering XERS - Xeris Pharmaceuticals:

Oren Livnat David Amsellem Difei Yang Randall Stanicky Vamil Divan Reuben Garner

Currently out of the existing stock ratings of XERS, 8 are a BUY (80%), 2 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$0.15 (1.91%)

$6.6

6 months 3 days ago
(07-Mar-2025)

11/12 (91.67%)

$3.76 (88.68%)

743

Hold

$4

$-3.85 (-49.04%)

$3

6 months 3 days ago
(07-Mar-2025)

4/4 (100%)

$-0.24 (-5.66%)

170

Buy

$4.5

$2.06 (84.43%)

$6.5

2 years 14 days ago
(28-Aug-2023)

0/2 (0%)

$2.23 (98.24%)

Buy

$6

$2.25 (60.00%)

3 years 5 months 25 days ago
(16-Mar-2022)

0/1 (0%)

$3.21 (115.05%)

Buy

$8

$0.15 (1.91%)

$9

4 years 1 months 4 days ago
(06-Aug-2021)

1/9 (11.11%)

$5.69 (246.32%)

38

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XERS (Xeris Pharmaceuticals) average time for price targets to be met?

On average it took 158.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.8

Which analyst has the current highest performing score on XERS (Xeris Pharmaceuticals) with a proven track record?

OREN LIVNAT

Which analyst has the current lower performing score on XERS (Xeris Pharmaceuticals) with a proven track record?

REUBEN GARNER

Which analyst has the most public recommendations on XERS (Xeris Pharmaceuticals)?

Oren Livnat works at HC WAINWRIGHT and has 6 price targets and 4 ratings on XERS

Which analyst is the currently most bullish on XERS (Xeris Pharmaceuticals)?

Vamil Divan with highest potential upside - $2.25

Which analyst is the currently most reserved on XERS (Xeris Pharmaceuticals)?

David Amsellem with lowest potential downside - -$3.85

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?